{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:03:45Z","timestamp":1791669825811,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00198-012-1911-3","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T11:44:52Z","timestamp":1328096692000},"page":"2703-2711","source":"Crossref","is-referenced-by-count":119,"title":["The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy"],"prefix":"10.1007","volume":"23","author":[{"given":"A. M.","family":"Sbrocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. J.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Matzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"1911_CR1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.nmd.2007.05.008","volume":"17","author":"AC Soderpalm","year":"2007","unstructured":"Soderpalm AC, Magnusson P, Ahlander AC, Karlsson J, Kroksmark AK, Tulinius M, Swolin-Eide D (2007) Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord 17:919\u2013928","journal-title":"Neuromuscul Disord"},{"key":"1911_CR2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1468-1331.2004.00866.x","volume":"11","author":"O Yilmaz","year":"2004","unstructured":"Yilmaz O, Karaduman A, Topaloglu H (2004) Prednisolone therapy in Duchenne muscular dystrophy prolongs ambulation and prevents scoliosis. Eur J Neurol 11:541\u2013544","journal-title":"Eur J Neurol"},{"key":"1911_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1067\/mpd.2001.109601","volume":"138","author":"WD Biggar","year":"2001","unstructured":"Biggar WD, Gingras M, Fehlings DL, Harris VA, Steele CA (2001) Deflazacort treatment of Duchenne muscular dystrophy. J Pediatr 138:45\u201350","journal-title":"J Pediatr"},{"key":"1911_CR4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","volume":"14","author":"ML Bianchi","year":"2003","unstructured":"Bianchi ML, Mazzanti A, Galbiati E, Saraifoger S, Dubini A, Cornelio F, Morandi L (2003) Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 14:761\u2013767","journal-title":"Osteoporos Int"},{"key":"1911_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004694-200001000-00016","volume":"20","author":"CM Larson","year":"2000","unstructured":"Larson CM, Henderson RC (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20:71\u201374","journal-title":"J Pediatr Orthop"},{"key":"1911_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/000992280304200408","volume":"42","author":"JE Bothwell","year":"2003","unstructured":"Bothwell JE, Gordon KE, Dooley JM, MacSween J, Cummings EA, Salisbury S (2003) Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr (Phila) 42:353\u2013356","journal-title":"Clin Pediatr (Phila)"},{"key":"1911_CR7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, Mendell JR, Kissel JT (2007) Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 68:1607\u20131613","journal-title":"Neurology"},{"key":"1911_CR8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pediatrneurol.2007.11.001","volume":"38","author":"S Houde","year":"2008","unstructured":"Houde S, Filiatrault M, Fournier A, Dube J, D'Arcy S, Berube D, Brousseau Y, Lapierre G, Vanasse M (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38:200\u2013206","journal-title":"Pediatr Neurol"},{"key":"1911_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0960-8966(01)00307-8","volume":"12","author":"B Talim","year":"2002","unstructured":"Talim B, Malaguti C, Gnudi S, Politano L, Merlini L (2002) Vertebral compression in Duchenne muscular dystrophy following deflazacort. Neuromuscul Disord: NMD 12:294\u2013295","journal-title":"Neuromuscul Disord: NMD"},{"key":"1911_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.apmr.2004.04.021","volume":"86","author":"GA Hawker","year":"2005","unstructured":"Hawker GA, Ridout R, Harris VA, Chase CC, Fielding LJ, Biggar WD (2005) Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy. Arch Phys Med Rehabil 86:284\u2013288","journal-title":"Arch Phys Med Rehabil"},{"key":"1911_CR11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947\u2013952","journal-title":"N Engl J Med"},{"key":"1911_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000075589","volume":"61","author":"Z Sumnik","year":"2004","unstructured":"Sumnik Z, Land C, Rieger-Wettengl G, Korber F, Stabrey A, Schoenau E (2004) Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry. Horm Res 61:137\u2013142","journal-title":"Horm Res"},{"key":"1911_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00005792-199707000-00005","volume":"76","author":"C Brumsen","year":"1997","unstructured":"Brumsen C, Hamdy NA, Papapoulos SE (1997) Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Med (Baltimore) 76:266\u2013283","journal-title":"Med (Baltimore)"},{"key":"1911_CR14","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1096\/fj.01-0640fje","volume":"16","author":"RI Gafni","year":"2002","unstructured":"Gafni RI, McCarthy EF, Hatcher T, Meyers JL, Inoue N, Reddy C, Weise M, Barnes KM, Abad V, Baron J (2002) Recovery from osteoporosis through skeletal growth: early bone mass acquisition has little effect on adult bone density. FASEB J 16:736\u2013738","journal-title":"FASEB J"},{"key":"1911_CR15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1359\/jbmr.090213","volume":"24","author":"F Rauch","year":"2009","unstructured":"Rauch F, Munns CF, Land C, Cheung M, Glorieux FH (2009) Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Bone Miner Res 24:1282\u20131289","journal-title":"J Bone Miner Res"},{"key":"1911_CR16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.090712","volume":"25","author":"N Bishop","year":"2010","unstructured":"Bishop N, Harrison R, Ahmed F et al (2010) A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta. J Bone Miner Res 25:32\u201340","journal-title":"J Bone Miner Res"},{"key":"1911_CR17","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137\u20131148","journal-title":"J Bone Miner Res"},{"key":"1911_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1542\/peds.109.1.45","volume":"109","author":"CL Ogden","year":"2002","unstructured":"Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45\u201360","journal-title":"Pediatrics"},{"key":"1911_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","volume":"44","author":"WA Marshall","year":"1969","unstructured":"Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291\u2013303","journal-title":"Arch Dis Child"},{"key":"1911_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","volume":"45","author":"WA Marshall","year":"1970","unstructured":"Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13\u201323","journal-title":"Arch Dis Child"},{"key":"1911_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"1911_CR22","volume-title":"Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, fluoride","author":"Institute of Medicine","year":"1997","unstructured":"Institute of Medicine (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, fluoride. National Academy, Washington"},{"key":"1911_CR23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1210\/jc.2006-1706","volume":"92","author":"M Rauchenzauner","year":"2007","unstructured":"Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Hogler W (2007) Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2\u00a0months to 18\u00a0years. J Clin Endocrinol Metab 92:443\u2013449","journal-title":"J Clin Endocrinol Metab"},{"key":"1911_CR24","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford","edition":"2"},{"key":"1911_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004424-196801000-00005","volume":"3","author":"RP Spencer","year":"1968","unstructured":"Spencer RP, Sagel SS, Garn SM (1968) Age changes in five parameters of metacarpal growth. Invest Radiol 3:27\u201334","journal-title":"Invest Radiol"},{"key":"1911_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajpa.1330450207","volume":"45","author":"SM Garn","year":"1976","unstructured":"Garn SM, Mayor GH, Shaw HA (1976) Paradoxical bilateral asymmetry in bone size and bone mass in the hand. Am J Phys Anthropol 45:209\u2013210","journal-title":"Am J Phys Anthropol"},{"key":"1911_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S8756-3282(95)00162-X","volume":"17","author":"H Kroger","year":"1995","unstructured":"Kroger H, Vainio P, Nieminen J, Kotaniemi A (1995) Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone 17:157\u2013159","journal-title":"Bone"},{"key":"1911_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/adc.87.4.341","volume":"87","author":"IM Sluis van der","year":"2002","unstructured":"van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM (2002) Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child 87:341\u2013347, discussion 341-347","journal-title":"Arch Dis Child"},{"key":"1911_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jocd.2007.10.002","volume":"11","author":"G Armbrecht","year":"2008","unstructured":"Armbrecht G, Blenk T, Chesnut CH 3rd, Gardner JC, von Ingersleben G, Mahoney P, Felsenberg D (2008) Vertebral fracture diagnosis in the multinational BONE study of oral ibandronate: quality management in radiology. J Clin Densitom 11:221\u2013231","journal-title":"J Clin Densitom"},{"key":"1911_CR30","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1359\/jbmr.1999.14.8.1449","volume":"14","author":"P Ravaud","year":"1999","unstructured":"Ravaud P, Reny JL, Giraudeau B, Porcher R, Dougados M, Roux C (1999) Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res: Off J Am Soc Bone Miner Res 14:1449\u20131456","journal-title":"J Bone Miner Res : Off J Am Soc Bone Miner Res"},{"key":"1911_CR31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1191\/096228099673819272","volume":"8","author":"JM Bland","year":"1999","unstructured":"Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135\u2013160","journal-title":"Stat Methods Med Res"},{"key":"1911_CR32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S8756-3282(99)00257-4","volume":"26","author":"FH Glorieux","year":"2000","unstructured":"Glorieux FH, Travers R, Taylor A, Bowen JR, Rauch F, Norman M, Parfitt AM (2000) Normative data for iliac bone histomorphometry in growing children. Bone 26:103\u2013109","journal-title":"Bone"},{"issue":"Suppl 2","key":"1911_CR33","doi-asserted-by":"crossref","first-page":"P110","DOI":"10.1359\/jbmr.06s221","volume":"21","author":"FH Glorieux","year":"2006","unstructured":"Glorieux FH, Rauch F (2006) Medical therapy of children with fibrous dysplasia. J Bone Miner Res 21(Suppl 2):P110\u2013P113","journal-title":"J Bone Miner Res"},{"key":"1911_CR34","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"F Rauch","year":"2002","unstructured":"Rauch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293\u20131299","journal-title":"J Clin Invest"},{"key":"1911_CR35","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1359\/JBMR.050213","volume":"20","author":"CF Munns","year":"2005","unstructured":"Munns CF, Rauch F, Travers R, Glorieux FH (2005) Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 20:1235\u20131243","journal-title":"J Bone Miner Res"},{"key":"1911_CR36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jocd.2007.12.002","volume":"11","author":"S Baim","year":"2008","unstructured":"Baim S, Leonard MB, Bianchi ML, Hans DB, Kalkwarf HJ, Langman CB, Rauch F (2008) Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6\u201321","journal-title":"J Clin Densitom"},{"key":"1911_CR37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2214\/AJR.09.3065","volume":"194","author":"AM Gaca","year":"2010","unstructured":"Gaca AM, Barnhart HX, Bisset GS 3rd (2010) Evaluation of wedging of lower thoracic and upper lumbar vertebral bodies in the pediatric population. AJR Am J Roentgenol 194:516\u2013520","journal-title":"AJR Am J Roentgenol"},{"key":"1911_CR38","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1210\/en.2009-1488","volume":"151","author":"RS Weinstein","year":"2010","unstructured":"Weinstein RS, Jilka RL, Almeida M, Roberson PK, Manolagas SC (2010) Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice. Endocrinology 151:2641\u20132649","journal-title":"Endocrinology"},{"key":"1911_CR39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1017\/S0012162206001526","volume":"48","author":"H Plotkin","year":"2006","unstructured":"Plotkin H, Coughlin S, Kreikemeier R, Heldt K, Bruzoni M, Lerner G (2006) Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. Dev Med Child Neurol 48:709\u2013712","journal-title":"Dev Med Child Neurol"},{"key":"1911_CR40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/17518420903236270","volume":"13","author":"W Howe","year":"2010","unstructured":"Howe W, Davis E, Valentine J (2010) Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions. Dev Neurorehabil 13:31\u201336","journal-title":"Dev Neurorehabil"},{"issue":"Suppl 1","key":"1911_CR41","first-page":"S85","volume":"82","author":"FH Glorieux","year":"2008","unstructured":"Glorieux FH, Bishop N, Bober M et al (2008) Intravenous zoledronic acid (zol) compared to IV pamidronate (PAM) in children with severe osteogenesis imperfecta (OI). Calcif Tissue Int 82(Suppl 1):S85","journal-title":"Calcif Tissue Int"},{"key":"1911_CR42","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1359\/jbmr.090202","volume":"24","author":"J Halton","year":"2009","unstructured":"Halton J, Gaboury I, Grant R et al (2009) Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 24:1326\u20131334","journal-title":"J Bone Miner Res"},{"key":"1911_CR43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/acr.20171","volume":"62","author":"A Huber","year":"2010","unstructured":"Huber A, Gaboury I, Cabral DA et al (2010) Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders. Arth Care Res 62:516\u2013526","journal-title":"Arth Care Res"},{"issue":"1","key":"1911_CR44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/acr.20589","volume":"64","author":"C Rodd","year":"2012","unstructured":"Rodd C, Lang B, Ramsay T et al (2012) Incident vertebral fractures among children with rheumatic disorders 12\u00a0months post-glucocorticoid initiation: a national observational study. Arthritis Care Res 64(1):122\u2013131","journal-title":"Arthritis Care Res"},{"key":"1911_CR45","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.85.6.2122","volume":"85","author":"M Thearle","year":"2000","unstructured":"Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, Harbison M, Berdon W, Oberfield SE (2000) Osteoporosis: an unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab 85:2122\u20132126","journal-title":"J Clin Endocrinol Metab"},{"key":"1911_CR46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/adc.85.6.492","volume":"85","author":"NA Pandya","year":"2001","unstructured":"Pandya NA, Meller ST, MacVicar D, Atra AA, Pinkerton CR (2001) Vertebral compression fractures in acute lymphoblastic leukaemia and remodelling after treatment. Arch Dis Child 85:492\u2013493","journal-title":"Arch Dis Child"},{"key":"1911_CR47","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.bone.2011.07.031","volume":"49","author":"PJ Simm","year":"2011","unstructured":"Simm PJ, Johannesen J, Briody J, McQuade M, Hsu B, Bridge C, Little DG, Cowell CT, Munns CF (2011) Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2\u00a0years of treatment in children with secondary osteoporosis. Bone 49:939\u2013943","journal-title":"Bone"},{"key":"1911_CR48","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1542\/peds.2010-1666","volume":"127","author":"KE Gordon","year":"2011","unstructured":"Gordon KE, Dooley JM, Sheppard KM, MacSween J, Esser MJ (2011) Impact of bisphosphonates on survival for patients with Duchenne muscular dystrophy. Pediatrics 127:e353\u2013e358","journal-title":"Pediatrics"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-1911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-012-1911-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-012-1911-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T00:10:13Z","timestamp":1561248613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-012-1911-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s00198-012-1911-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]}}}